59 
IAM's Role in the Pharmaceutical Sector
Data Breach Today
JULY 8, 2019
Sandy Dalal of Allergan on Achieving Security Stability Mergers and acquisitions, along with cloud adoption, are rapidly changing the pharmaceutical industry.
Healthcare Related Topics 
Pharmaceutical companies exploited by phishing scam targeting job seekers
IT Governance
MAY 16, 2019
Earlier this month, two major pharmaceutical giants issued warnings about phishing emails targeting job hunters. The post Pharmaceutical companies exploited by phishing scam targeting job seekers appeared first on IT Governance Blog.
Trending Sources
Life Sciences at Enterprise World 2019
OpenText Information Management
AUGUST 26, 2019
For the past three years, OpenText™ Enterprise World in July has been the destination of choice for business leaders and partners who have invested in Enterprise Information Management with OpenText.
Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges
Hunton Privacy
MAY 19, 2016
Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The criminal charges stem from the company’s marketing of a cholesterol drug called Juxtapid.
Reimagining patient centricity and healthcare practitioner engagement for 2020
DXC Technology
APRIL 30, 2019
Life Sciences analytics healthcare pharmaceuticalby Satish Pandelenghat and Manjunath Shanabag The relationship between the life sciences industry and healthcare practitioners has changed dramatically in recent years.
ISO identification of medicinal products (IDMP)
OpenText Information Management
FEBRUARY 26, 2018
Enterprise Content Management Information Management EIM ISO IDMP Life sciences pharmaceuticalIn a previous blog I looked at some of the EU regulations that are disrupting the Life Sciences sector.
|
Introducing OpenText Life Sciences Express – it’s simple
OpenText Information Management
MARCH 13, 2018
Simplicity. That’s what every Life Sciences professional working with regulated business processes needs today. That’s exactly what they’re getting with the intuitive user experience and efficient cloud-based access of our new OpenText™ Life Sciences Express. Here’s why simplicity is so important.
Making Internal Audits More Relevant
Data Breach Today
DECEMBER 13, 2018
Prasanna Bharatan, internal auditor at the pharmaceutical company Wockhardt, outlines the important steps to take Wockhardt's Prasanna Bharatan on Why Audits Often Are Not Meaningful How can improve internal audits be improved and made more meaningful?
The hidden threats facing your intellectual property
IT Governance
SEPTEMBER 4, 2018
For life sciences and pharmaceutical companies, this includes data on the development and testing of new therapies and details of how therapies are manufactured. Cyber Resilience Healthcare Intellectual Property Life Sciences Pharmaceutical
Business Process Modeling Use Cases and Definition
erwin
MARCH 28, 2019
This also extends to industry-specific other compliance mandates such as those in healthcare, pharmaceutical and the financial services industries. What is business process modeling (BPM)? A visual representation of what your business does and how it does it.
Former Physician Convicted of Criminal HIPAA Violation
Data Breach Today
MAY 4, 2018
The case was tied to providing a pharmaceutical salesperson access to patients' medical records Case Involved Unauthorized Access to Patient Records A former Massachusetts gynecologist has been convicted in a rare case involving a criminal HIPAA violation.
|
With a focus on seamless sharing across domains, OpenText Documentum for Life Sciences 16.4 takes a giant leap forward
OpenText Information Management
JULY 3, 2018
When major acquisitions happen, market analysts, competitors, customers, and employees alike are watching closely to determine what’s next.
My Health Record 'identical' to failed UK scheme, privacy expert says
The Guardian Data Protection
JULY 21, 2018
Health Data protection Australia news Technology Privacy Pharmaceuticals industryCare.data was cancelled because drug and insurance companies were able to buy patient data Australia’s impending My Health Record system is “identical” to a failed system in England that was cancelled after it was found to be selling patient data to drug and insurance companies , a British privacy expert has said.
Maintaining Regulatory-Compliant Cloud Solutions
Perficient Data & Analytics
JUNE 1, 2018
Cloud Data & Analytics Digital Transformation Integration & IT Modernization Life Sciences Operations Regulatory Compliance Strategy 21 CFR Part 11 clinical cloud compliance Data hosting IaaS medical device PaaS pharmaceutical Regulatory SaaS Software Systems technology
Who Is Responsible For The Compliance Of Cloud Systems?
Perficient Data & Analytics
JUNE 21, 2018
Cloud Data & Analytics Digital Transformation Integration & IT Modernization Life Sciences Operations Regulatory Compliance Strategy 21 CFR Part 11 clinical cloud compliance Data hosting IaaS medical device PaaS pharmaceutical Regulatory SaaS Software Systems technologyAny time you take advantage of a cloud service – infrastructure, platform, or software – for a regulated purpose, you are ultimately responsible for its regulatory compliance, not the cloud vendor.
Refresher: Which IT Systems Are Regulated
Perficient Data & Analytics
JUNE 7, 2018
Cloud Data & Analytics Digital Transformation Integration & IT Modernization Life Sciences Operations Regulatory Compliance Strategy 21 CFR Part 11 clinical cloud compliance Data hosting IaaS medical device PaaS pharmaceutical Regulatory SaaS Software Systems technologyIf your company makes drugs, medical devices, or biologics (vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins), it is regulated.
Key Takeaways About Compliant IT Systems In The Cloud
Perficient Data & Analytics
JULY 19, 2018
Cloud Data & Analytics Digital Transformation Integration & IT Modernization Life Sciences Operations Regulatory Compliance Strategy 21 CFR Part 11 clinical cloud compliance Data hosting IaaS medical device PaaS pharmaceutical Regulatory SaaS Software Systems technologyThis is the final post in our series on maintaining regulatory-compliant IT systems in the cloud. In this post, we’ll go over the key takeaways from the series and then we’ll send you on your way!
How To Qualify Cloud Vendors
Perficient Data & Analytics
JUNE 28, 2018
Because the ultimate responsibility for regulatory compliance lies with you – the pharmaceutical or medical device company – you need to be much more proactive and critical. Cloud Data & Analytics Digital Transformation Integration & IT Modernization Life Sciences Operations Regulatory Compliance Strategy 21 CFR Part 11 clinical cloud compliance Data hosting IaaS medical device PaaS pharmaceutical Regulatory SaaS Software Systems technology
Ensuring quality control and compliance
OpenText Information Management
SEPTEMBER 3, 2019
How does an emerging pharmaceutical company manage rapid growth, protect its intellectual property (IP) and comply with strict regulatory requirements?
How To Use Contracts For Regulatory Compliance Of Cloud Systems
Perficient Data & Analytics
JULY 5, 2018
Cloud Data & Analytics Digital Transformation Integration & IT Modernization Life Sciences Operations Regulatory Compliance Strategy 21 CFR Part 11 clinical cloud compliance Data hosting IaaS medical device PaaS pharmaceutical Regulatory SaaS Software Systems technologyIn the previous post in this series, we discussed how to qualify cloud vendors.
Introducing Box GxP Validation: Compliance for an Agile Cloud
Box
JANUARY 18, 2018
Organizations in the life sciences, including pharmaceuticals, biotech and medical device companies, are rapidly transforming.
Using a 'Privacy by Design' Approach to GDPR Compliance
Data Breach Today
MARCH 2, 2018
To prepare for compliance with the EU's GDPR, which will be enforced beginning in May, organizations must adopt a "privacy by design" approach, says Subhajit Deb, CISO at Dr. Reddy's Laboratories, an India headquartered pharmaceutical company that does business in 11 countries
Transforming pharma’s customer value chain with digital technologies
DXC Technology
MARCH 14, 2019
by Satish Nair and Manjunath Shanabag Pharmaceutical companies struggle with a complex and, often, poorly managed partner, customer and distribution network. It’s not surprising, given the makeup of most large pharma companies. Large, often disconnected product portfolios are built through discovery — both internally and externally with academia and biotech partners — and global clinical […]. Analytics Business Processes Life Sciences
China gets ready to launch eCTD, as companies face a challenging learning curve
DXC Technology
MAY 16, 2019
by Winnie Yang and Leslie Wan China is gearing up for the implementation of electronic Common Technical Document (eCTD) submissions to accelerate the review and approval of new pharmaceuticals. A year after officially introducing the subject, the life sciences industry in this country is starting to see greater momentum toward implementation. Publication of official specifications […]. Life Sciences eCTD regulatory compliance regulatory content management
Regulatory Matters: EU regulatory change is coming fast in Life Sciences
OpenText Information Management
JANUARY 25, 2018
However, the next few years are about to see major new legislation in the EU that could result in major disruption to Life Sciences, Pharmaceutical and Healthcare companies – wherever they are. The Life Sciences sector is used to constant regulatory change.
Implementing a real-time catalog of enterprise data assets
Information Management Resources
MARCH 15, 2018
Beyond defining access privileges, effective data governance means that companies need to be able to document or label their data assets, much like the labels on pharmaceuticals. Data management Data visualization Data discovery
More Attacks against Computer Automatic Update Systems
Schneier on Security
MAY 16, 2019
Also, our experts identified three additional victims: another video gaming company, a conglomerate holding company and a pharmaceutical company, all in South Korea.
My Health Record: big pharma can apply to access data
The Guardian Data Protection
SEPTEMBER 17, 2018
‘Each application would be assessed on its own merits,’ senators told Pharmaceutical companies will be allowed to apply for data from the controversial My Health Record system, a Senate committee hearing has been told. Caroline Edwards, the deputy secretary of the Department of Health, told the committee third-party access arrangements would allow medical and public health researchers access to de-identified data. Continue reading.
Is Co-Authoring the Right Prescription for You?
AIIM
AUGUST 8, 2019
Pharmaceutical and Life Science are good examples of industries that are feeling the pain. Start by downloading the latest tip sheet from AIIM, “ Co-Authoring Tools Provide the Right Prescription for Pharmaceutical and Life Science Success.” Several months ago, I developed a nagging pain in my right shoulder. Nothing much at first, but over time, it got worse. Initially, I ignored the pain and hoped it would resolve itself. But it didn’t.
Malvertising campaign exploits recently disclosed WordPress Plugin flaws
Security Affairs
JULY 24, 2019
“The Defiant Threat Intelligence team has identified a malvertising campaign which is causing victims’ sites to display unwanted popup ads and redirect visitors to malicious destinations, including tech support scams, malicious Android APKs, and sketchy pharmaceutical ads.”
NEW TECH: How Semperis came to close a huge gap in Active Directory disaster preparedness
The Last Watchdog
APRIL 29, 2019
pharmaceutical giant Merck; the crippling of its AD tool resulted in suffering drug shortages and losing hundreds of millions of dollars ( latest estimation is 870 million ). In today’s complex IT environments, a million things can go wrong, though only a few systems touch everything.
This is the old ChiefTech blog.: Janssen-Cilag Wiki Case Study
ChiefTech
AUGUST 20, 2007
Tuesday, 21 August 2007 Janssen-Cilag Wiki Case Study Here is a great Aussie wiki case study shared by Nathan Wallace from Janssen-Cilag , a pharmaceutical subsidiary of Johnson & Johnson. This is the old ChiefTech blog. Nice of you to drop in and visit.
Chronicle experts spotted a Linux variant of the Winnti backdoor
Security Affairs
MAY 20, 2019
Chronicle researchers while investigating the cyber attack that hit the Bayer pharmaceutical company in April. “In April 2019, reports emerged of an intrusion involving Winnti malware at a German Pharmaceutical company.”
The Importance of EA/BP for Mergers and Acquisitions
erwin
JUNE 21, 2019
Industry-specific regulations in areas like healthcare, pharmaceuticals and financial services have been in place for some time.
German firms BASF, Siemens, Henkel hit by cyber attacks
Security Affairs
JULY 25, 2019
Recently Chronicle researchers while investigating the cyber attack that hit the Bayer pharmaceutical company in April spotted a Linux variant of the Winnti backdoor.
Episode 158: How NotPetya has Insurers grappling with Systemic Cyber Risk
The Security Ledger
AUGUST 20, 2019
And, for companies impacted, it was impressively damaging: halting production lines and operations at global corporations in shipping, pharmaceuticals and manufacturing. We talk to Bruce McDonnell of the East West Institute about how insurers are responding.
Why real-world evidence is a game changer for life sciences in the age of value-based care
DXC Technology
AUGUST 13, 2019
What that demands for pharmaceutical companies is better insight into the fair market value their products bring, or potentially will bring, to maximize all the benefits of those products. by Jared Kimble Value-based care is quickly becoming integral to the life sciences industry as the entire healthcare sector undergoes increased convergence.
ICO Announces First Data Protection Sandbox Participants
Hunton Privacy
JULY 30, 2019
The projects selected by the ICO include proposals by the Greater London Authority, Heathrow Airport Holding Limited (which is looking at the use of facial recognition technology to streamline passenger journeys), NHS Digital and the Ministry of Housing, Communities and Local Government, as well as private organizations such as FutureFlow, Novartis Pharmaceuticals UK Limited and Trust Elevate.
Q&A: The drivers behind the stark rise — and security implications — of ‘memory attacks’
The Last Watchdog
MAY 6, 2019
Merck had one of its pharmaceuticals delayed, which led to a global shortage. A distinctive class of hacking is rising to the fore and is being leveraged by threat actors to carry out deep, highly resilient intrusions of well-defended company networks. Related: Memory hacking becomes a go-to tactic These attacks are referred to in the security community as “fileless attacks” or “memory attacks.”
BEST PRACTICES: Rising complexities of provisioning identities has pushed ‘IGA’ to the fore
The Last Watchdog
APRIL 3, 2019
Its customer base is comprised of eight of the top 15 banks, four of the top six healthcare insurance and managed care providers, nine of the top 15 property and casualty insurance providers, five of the top 13 pharmaceutical companies, and 11 of the largest 15 federal agencies. Identity governance and administration, or IGA , has suddenly become a front-burner matter at many enterprises. Related: Identity governance issues in the age of digital transformation.
Let's personalize your content